Development and validation of therapeutically relevant multi-gene biomarker classifiers

Journal of the National Cancer Institute

Volumn 97, Issue 12, 2005, Pages 866-867

  Simon, Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HOX PROTEIN; INTERLEUKIN 17; RNA; TAMOXIFEN; TUMOR MARKER;

ANALYTICAL ERROR; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CLASSIFICATION; DNA MICROARRAY; EDITORIAL; GENE EXPRESSION PROFILING; HUMAN; LYMPH NODE METASTASIS; MONOTHERAPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING; VALIDATION PROCESS; ANIMAL; EVALUATION; GENETIC MARKER; GENETICS; LABORATORY DIAGNOSIS; NEOPLASM; NOTE; PREDICTION AND FORECASTING; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; EVALUATION STUDIES; FALSE POSITIVE REACTIONS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 21444445077     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji168     Document Type: Editorial

References (10)

1. Ma X, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5:607-16.
2. Reid JF, Lusa L, De Cecco L, Coradini D, Veneroni S, Grazia Daidone M, et al. Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst 2005;97:927-30.
3. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated node-negative breast cancer. N Engl J Med 2004;351:2817-26.
4. Simon R. Diagnostic and prognostic prediction using gene expression profiles in high dimensional microarray data. Br J Cancer 2003;89:1599-604.
5. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the analysis of DNA microarray data: Class prediction methods. J Natl Cancer Inst 2003;95:14-8.
6. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393-8.
7. Sgroi DC, Haber DA, Ryan PD, Ma Xj, Erlander MG. RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;6:445.
8. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Computational Biol 2002;9:505-11.
9. Simon R. When is a genomic classifier ready for prime time? Natl Clin Practice Oncol 2004;1:4-5.
10. Kattan MW. Evaluating a new marker's predictive contribution. Clin Cancer Res 2004;10:822-4.